Proqr Therapeutics Bv Stock Market Value
| PRQR Stock | USD 1.69 0.05 2.87% |
| Symbol | ProQR |
ProQR Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProQR Therapeutics. If investors know ProQR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProQR Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.35) | Revenue Per Share | Quarterly Revenue Growth 1.906 | Return On Assets | Return On Equity |
The market value of ProQR Therapeutics is measured differently than its book value, which is the value of ProQR that is recorded on the company's balance sheet. Investors also form their own opinion of ProQR Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is ProQR Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProQR Therapeutics' market value can be influenced by many factors that don't directly affect ProQR Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProQR Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProQR Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProQR Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ProQR Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ProQR Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ProQR Therapeutics.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in ProQR Therapeutics on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding ProQR Therapeutics BV or generate 0.0% return on investment in ProQR Therapeutics over 90 days. ProQR Therapeutics is related to or competes with Annexon, Arrowhead Pharmaceuticals, Day One, Terns Pharmaceuticals, Alnylam Pharmaceuticals, Wave Life, and Blueprint Medicines. ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics... More
ProQR Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ProQR Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ProQR Therapeutics BV upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 31.61 | |||
| Value At Risk | (8.58) | |||
| Potential Upside | 6.61 |
ProQR Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ProQR Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ProQR Therapeutics' standard deviation. In reality, there are many statistical measures that can use ProQR Therapeutics historical prices to predict the future ProQR Therapeutics' volatility.| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (0.91) | |||
| Total Risk Alpha | (0.07) | |||
| Treynor Ratio | (3.73) |
ProQR Therapeutics Backtested Returns
ProQR Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.1, which implies the firm had a -0.1 % return per unit of risk over the last 3 months. ProQR Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check ProQR Therapeutics' Risk Adjusted Performance of (0.14), variance of 27.13, and Coefficient Of Variation of (556.04) to confirm the risk estimate we provide. The company holds a Beta of 0.25, which implies not very significant fluctuations relative to the market. As returns on the market increase, ProQR Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding ProQR Therapeutics is expected to be smaller as well. At this point, ProQR Therapeutics has a negative expected return of -0.51%. Please make sure to check ProQR Therapeutics' total risk alpha, accumulation distribution, as well as the relationship between the Accumulation Distribution and period momentum indicator , to decide if ProQR Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.48 |
Average predictability
ProQR Therapeutics BV has average predictability. Overlapping area represents the amount of predictability between ProQR Therapeutics time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ProQR Therapeutics price movement. The serial correlation of 0.48 indicates that about 48.0% of current ProQR Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.48 | |
| Spearman Rank Test | 0.33 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
ProQR Therapeutics lagged returns against current returns
Autocorrelation, which is ProQR Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ProQR Therapeutics' stock expected returns. We can calculate the autocorrelation of ProQR Therapeutics returns to help us make a trade decision. For example, suppose you find that ProQR Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ProQR Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ProQR Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ProQR Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ProQR Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
ProQR Therapeutics Lagged Returns
When evaluating ProQR Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ProQR Therapeutics stock have on its future price. ProQR Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ProQR Therapeutics autocorrelation shows the relationship between ProQR Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in ProQR Therapeutics BV.
Regressed Prices |
| Timeline |
Pair Trading with ProQR Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ProQR Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProQR Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with ProQR Stock
Moving against ProQR Stock
| 0.6 | ETON | Eton Pharmaceuticals | PairCorr |
| 0.46 | PFE | Pfizer Inc | PairCorr |
| 0.42 | NBY | NovaBay Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to ProQR Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ProQR Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ProQR Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ProQR Therapeutics BV to buy it.
The correlation of ProQR Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ProQR Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ProQR Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ProQR Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for ProQR Stock Analysis
When running ProQR Therapeutics' price analysis, check to measure ProQR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProQR Therapeutics is operating at the current time. Most of ProQR Therapeutics' value examination focuses on studying past and present price action to predict the probability of ProQR Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProQR Therapeutics' price. Additionally, you may evaluate how the addition of ProQR Therapeutics to your portfolios can decrease your overall portfolio volatility.